David M.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of Molecular Targeted Maintenance Therapy with Binimetinib, Futibatinib, and Drug Combination in Advanced Biliary Cancer: A Phase 3 Randomized Trial
- Phase 3 Randomized, Double-Blind Study of Bemarituzumab with mFOLFOX6 in FGFR2b-Overexpressing Advanced Gastric or Gastroesophageal Junction Cancer
- Phase 1b/3 Evaluation of Bemarituzumab, Chemotherapy, and Nivolumab in FGFR2b-Overexpressing Advanced Gastric and Gastroesophageal Junction Cancer
Data & Insights
Has run more than one trial at 152 of 332 partner sites.
Specializations
Biliary Tract Oncology
The investigator specializes in treating advanced biliary tract cancers and cholangiocarcinoma, with particular expertise in developing personalized treatment approaches. Their research encompasses both systemic and targeted therapeutic strategies for biliary malignancies.
- Advanced Biliary Cancer (ABC)
- Locally Advanced Cholangiocarcinoma
- Adjuvant Therapy for Biliary Tract Carcinoma
The investigator evaluates novel therapeutic combinations including molecular targeted therapies and immunotherapy approaches for biliary tract malignancies.
Gastric Cancer Research
The investigator focuses on advancing treatment options for gastric and gastroesophageal junction adenocarcinomas, with particular emphasis on targeted therapies. Their work includes evaluation of novel therapeutic approaches for HER2-positive gastric cancers.
- Advanced Gastric Adenocarcinoma
- Gastroesophageal Junction Cancer
- FGFR2b-Overexpressing Gastric Cancer
Their research explores innovative combination strategies incorporating targeted agents, immunotherapy, and conventional chemotherapy.
Pancreatic Cancer Treatment
The investigator conducts research in pancreatic adenocarcinoma treatment, focusing on optimizing therapeutic strategies for patients who require alternative treatment approaches. Their work evaluates various chemotherapy combinations.
- Metastatic Pancreatic Adenocarcinoma
- First-line Treatment Optimization
- Alternative Chemotherapy Protocols
The research aims to establish more effective treatment options for patients who cannot receive standard intensive therapy regimens.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.